PhRMA: Market overreacted to Obama plans

In another layer of support for President Obama's healthcare reform plans, PhRMA chief Billy Tauzin said drug companies won't lose even if universal healthcare ends up depressing pharma prices. That's because drugmakers would sell more of the lower-priced meds, making up in volume what they lose on price cuts. Report